Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 35, 2013 - Issue 5
Submit an article Journal homepage
225
Views
3
CrossRef citations to date
0
Altmetric
Short Communication

Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports

Nizar SouayahDepartment of Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey Newark, NJUSACorrespondence[email protected]
,
Raje NoopurDivision of Hematology/Oncology, Massachusetts General Hospital Cancer Center Boston, MAUSA
&
Peter Siao Tick-ChongDepartment of Neurology, Boston University Boston, MAUSA
Pages 622-624 | Received 26 Feb 2013, Accepted 02 Jul 2013, Published online: 15 Aug 2013

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jean-Michel Vallat, Laurent Magy, Jonathan Ciron, Philippe Corcia, Gwendal Le Masson & Stéphane Mathis. (2016) Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies. Expert Review of Neurotherapeutics 16:9, pages 1111-1119.
Read now

Articles from other publishers (2)

Pascal Hänggi, Butrint Aliu, Kea Martin, Ruben HerrendorffAndreas Johann Steck. (2022) Decrease in Serum Anti-MAG Autoantibodies Is Associated With Therapy Response in Patients With Anti-MAG Neuropathy. Neurology Neuroimmunology & Neuroinflammation 9:1.
Crossref
Alexandra Gomez & James E. Hoffman. (2016) Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature. Clinical Lymphoma Myeloma and Leukemia 16:7, pages e101-e108.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.